News

Malay Mail
malaymail. com > news > life > 04/19/2026 > malaysian-scientist-swee-lay-thein-shares-us3m-breakthrough-prize-for-pioneering-gene-editing-research > 216884

Malaysian scientist Swee Lay Thein shares US$3m Breakthrough Prize for pioneering gene-editing research

9+ hour, 16+ min ago  (254+ words) LOS ANGELES, April 19 " Malaysian physician-scientist Dr Swee Lay Thein and American researcher Dr Stuart H. Orkin have won the US$3 million (RM11. 86 million) Breakthrough Prize in Life Sciences for research that helped create the first approved CRISPR gene-editing therapy. According to a…...

bioworld. com
bioworld. com > articles > 730390-storm-raises-56m-series-c-for-phase-ii-rna-inhibitor-trial-in-sarcoma

Storm raises $56 M series C for phase II RNA inhibitor trial in sarcoma

3+ day, 17+ hour ago  (56+ words) RNA epigenetics specialist Storm Therapeutics Ltd. has closed a $56 million series C to fund phase II development of its lead RNA enzyme inhibitor, STC-15, in treating myo- and liposarcomas, and announced that the first patient has been treated in the…...

Yahoo News
yahoo. com > news > articles > 3-million-prize-goes-duo-000000809. html

$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy

3+ hour, 53+ min ago  (802+ words) Two scientists whose work ushered in the first approved therapy using the gene-editing tool CRISPR have won the $3 million Breakthrough Prize in Life Sciences. The prize winners " Dr. Swee Lay Thein, of the National Heart, Lung and Blood Institute (NHLBI),…...

Medium
medium. com > @prehealthspotlight > duality-of-gene-splicing-598a2a2737b3

Duality of Gene Splicing

8+ hour, 40+ min ago  (599+ words) Samuel Stanbro (Fall 2024) For several decades, there has been ongoing research and development in the field of gene splicing, sometimes also referred to as gene therapy " Duality of Gene Splicing Samuel Stanbro (Fall 2024) For several decades, there has been ongoing…...

Inquirer. com
inquirer. com > health > breakthrough-prize-2026-philadelphia-scientists-gene-therapy-blindness-20260418. html

Philly scientists win 2026 Breakthrough Prize for developing gene therapy for blindness

18+ hour, 41+ min ago  (1356+ words) Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish Philadelphia as a biotech hub. Three Philadelphia scientists won a $3 million Breakthrough Prize for developing the first FDA-approved gene therapy…...

@nature
nature. com > articles > d41586-026-01014-9

Magnetic muon measurements and gene-therapy advances win US$3 million Breakthrough prizes

1+ day, 6+ hour ago  (728+ words) David Hertzog and Katherine High were among the winners of this year's Breakthrough prize. Credit: Dennis R. Wise & Colin Lenton Last year, the particle-physics and accelerator laboratory Fermilab announced the final results of its measurements of the muon's magnetic moment, which…...

Devdiscourse
devdiscourse. com > article > science-environment > 3879347-crispr-gene-editing-breakthrough-hope-for-down-syndrome

CRISPR Gene Editing: Breakthrough Hope for Down Syndrome | Science-Environment

20+ hour, 29+ min ago  (602+ words) In a groundbreaking development researchers have engineered a modified version of the CRISPR gene-editing tool This innovation shows potential to silence the extra chromosome responsible for Down syndrome as indicated by early laboratory experiments Down syndrome is a genetic condition…...

Eurek Alert!
eurekalert. org > multimedia > 1126323

Medicine's next leap: Delivering gene therapies exactly where they're needed

2+ day, 58+ min ago  (112+ words) "It's kind of like we just discovered that cells use a new media like phones or Tik Tok for communication and not only face-to-face conversation," says'Dr. Derrick Gibbings, Professor and Associate Vice-President, Research Support and Infrastructure at the University of…...

Chemical & Engineering News
cen. acs. org > pharmaceuticals > process-chemistry > Jason-S-Tedrow-adapts-new-technologies-to-scale-up-drug-manufacturing > 100 > i12

Jason S. Tedrow adapts new technologies to scale up drug manufacturing

1+ week, 2+ day ago  (493+ words) As Sanofi's head of process chemistry, he mixes traditional chemistry with flow chemistry and new biocatalysts to reduce costs and improve efficiency by Neil Savage, special to C&EN A version of this story appeared in Volume 100, Issue 12 A yearly…...

RAPS. org
raps. org > resource > expert-fda-industry-still-wary-of-enrolling-patients-in-early-cell-and-gene-therapy-trials. html

Expert: FDA, industry still wary of enrolling patients in early cell and gene therapy trials

1+ week, 2+ day ago  (946+ words) A cutting-edge reference for mastering regulatory intelligence in the age of AI. This 28-chapter guide combines expert insights with real-world stories and practical frameworks. The new member-exclusive RAPS Journal of Regulatory Affairs, a bimonthly, peer-reviewed publication building on the success…...